|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
229,860,000 |
Market
Cap: |
485.00(M) |
Last
Volume: |
562,074 |
Avg
Vol: |
229,763 |
52
Week Range: |
$1.45 - $5.46 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 4.1 |
Insider 6 Months : 4.1 |
Insider 3/6 Months : 8.5 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Palatin Technologies is a biopharmaceutical company developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Co.'s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Co.'s primary product, Vyleesi®, is a melanocortin receptor agonist, is an as needed therapy used in anticipation of sexual activity and self-administered in the thigh or abdomen via a single-use subcutaneous auto-injector by premenopausal women with hypoactive sexual desire disorder.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
6,000 |
6,000 |
6,000 |
26,000 |
Total Buy Value |
$12,703 |
$12,703 |
$12,703 |
$57,245 |
Total People Bought |
1 |
1 |
1 |
3 |
Total Buy Transactions |
1 |
1 |
1 |
3 |
Total Shares Sold |
11,700 |
16,898 |
16,898 |
16,898 |
Total Sell Value |
$23,434 |
$36,493 |
$36,493 |
$36,493 |
Total People Sold |
1 |
3 |
3 |
3 |
Total Sell Transactions |
1 |
3 |
3 |
3 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lampert Mark N |
10% Owner |
|
2014-02-27 |
4 |
S |
$1.09 |
$320,269 |
I/I |
(293,825) |
2,494,521 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2014-02-26 |
4 |
S |
$1.11 |
$50,359 |
I/I |
(45,397) |
2,695,348 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2014-02-25 |
4 |
S |
$1.12 |
$247,143 |
I/I |
(220,742) |
2,728,584 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2014-02-24 |
4 |
S |
$1.16 |
$318,382 |
I/I |
(274,042) |
2,880,119 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2014-02-19 |
4 |
S |
$1.11 |
$48,494 |
I/I |
(43,606) |
3,071,923 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2014-02-18 |
4 |
S |
$1.18 |
$274,860 |
I/I |
(233,328) |
541,393 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2014-02-14 |
4 |
S |
$1.16 |
$33,709 |
I/I |
(29,032) |
652,278 |
|
- |
|
Wills Stephen T |
Executive VP and CFO/COO |
|
2013-09-04 |
4 |
D |
$0.69 |
$11,544 |
D/D |
(16,731) |
310,488 |
|
- |
|
Wills Stephen T |
Executive VP and CFO/COO |
|
2013-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,000 |
327,219 |
|
- |
|
Spana Carl |
President & CEO |
|
2013-09-04 |
4 |
D |
$0.69 |
$13,670 |
D/D |
(19,812) |
325,841 |
|
- |
|
Spana Carl |
President & CEO |
|
2013-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
56,250 |
345,653 |
|
- |
|
Wills Stephen T |
Executive VP and CFO/COO |
|
2013-06-22 |
4 |
D |
$0.65 |
$22,245 |
D/D |
(34,223) |
272,219 |
|
- |
|
Wills Stephen T |
Executive VP and CFO/COO |
|
2013-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
112,500 |
306,442 |
|
- |
|
Spana Carl |
President & CEO |
|
2013-06-22 |
4 |
D |
$0.65 |
$27,910 |
D/D |
(42,938) |
289,403 |
|
- |
|
Spana Carl |
President & CEO |
|
2013-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
125,000 |
332,341 |
|
- |
|
Dunton Alan W |
Director |
|
2013-03-19 |
4 |
B |
$0.58 |
$580 |
I/I |
1,000 |
7,520 |
2.02 |
- |
|
Dunton Alan W |
Director |
|
2013-02-01 |
4 |
B |
$0.58 |
$1,170 |
I/I |
2,000 |
6,520 |
2.02 |
- |
|
Taber Robert I |
Director |
|
2013-01-28 |
4 |
B |
$0.59 |
$2,950 |
I/I |
5,000 |
5,500 |
2.1 |
- |
|
Spana Carl |
President & CEO |
|
2012-12-31 |
4 |
B |
$0.57 |
$5,727 |
D/D |
10,000 |
207,341 |
2.81 |
- |
|
Wills Stephen T |
Executive VP and CFO/COO |
|
2012-12-28 |
4 |
B |
$0.56 |
$5,600 |
D/D |
10,000 |
193,942 |
2.74 |
- |
|
Molinoff Perry B |
Director |
|
2012-12-24 |
4 |
B |
$0.61 |
$6,099 |
D/D |
10,000 |
11,000 |
2.39 |
- |
|
Hull Joseph Stanley |
Director |
|
2012-12-24 |
4 |
B |
$0.65 |
$1,298 |
D/D |
2,000 |
2,000 |
2.31 |
- |
|
Horovitz Zola P |
Director |
|
2012-12-24 |
4 |
B |
$0.60 |
$6,000 |
D/D |
10,000 |
10,500 |
2.39 |
- |
|
Deveer Robert K Jr |
Director |
|
2012-12-14 |
4 |
B |
$0.70 |
$4,872 |
I/I |
6,960 |
22,060 |
2.1 |
- |
|
Deveer Robert K Jr |
Director |
|
2012-12-14 |
4 |
B |
$0.70 |
$10,457 |
D/D |
15,000 |
15,100 |
2.39 |
- |
|
248 Records found
|
|
Page 8 of 10 |
|
|